Syringes, Needles, and Catheters: Essential Health Care Standards for Safety, Productivity, and Innovation
- Valentina Bosenko
- 2 days ago
- 8 min read
In today’s rapidly evolving health care industry, the safe and efficient use of syringes, needles, and catheters is more critical than ever. With advanced medical technologies, automation in drug delivery, and growing requirements for patient-centric solutions, the adoption of robust international standards has become a necessity for businesses, manufacturers, and medical practitioners. This article explores three pivotal standards—ISO 11040-7:2024, ISO 11608-1:2022, and ISO 23217:2024—detailing their objectives, requirements, and the ways they enhance productivity, security, and scalability in modern health care environments. By adhering to these up-to-date specifications, organizations not only meet global compliance but also gain a competitive edge in reliability, risk reduction, and technological innovation.
Overview / Introduction
Syringes, needles, and catheters are the backbone of medication administration, infusion therapy, and patient self-care management. In health care facilities, pharmaceuticals, and biotech sectors, the accuracy, sterility, and usability of these devices are non-negotiable. International standards ensure that these devices are designed, manufactured, packaged, and labeled under stringent safety and quality controls. This not only protects patients but also helps businesses streamline manufacturing, automate processes, and leverage new technologies confidently.
Implementing these standards brings numerous benefits:
Enhanced safety and reduced risk of contamination or dosing errors
Streamlined regulatory approval and smoother market entry
Increased productivity and process efficiency, especially with automation
Better patient outcomes, including pediatric and self-administration scenarios
In this article, you’ll learn how ISO 11040-7:2024, ISO 11608-1:2022, and ISO 23217:2024 set the benchmarks for:
Packaging of sterilized subassembled syringes
Testing and validation of needle-based injection systems
Special design requirements for pediatric self-injection
Detailed Standards Coverage
ISO 11040-7:2024 - Packaging Systems for Sterilized Subassembled Syringes Ready for Filling
Prefilled syringes — Part 7: Packaging systems for sterilized subassembled syringes ready for filling
This international standard defines the packaging systems used to deliver sterilized, subassembled syringes—preassembled but not yet filled with medication—to pharmaceuticals and health care providers. As global demand for ready-to-fill solutions increases, packaging must maintain microbiological sterility, structural integrity, and compatibility with automated processing equipment. ISO 11040-7:2024 sets out requirements for the nest and tub configurations, protective liners, sealing lids, and multilayer bag assemblies that together ensure both protection and ease of use across highly automated production and aseptic environments.
Scope & Context
Applies to packaging systems that deliver sterilized subassembled syringes ready for filling in tubs and nests.
Covers not only the structural features (nests, tubs, liners, seals) but also the materials and barrier integrity needed to maintain sterility during storage, transport, and filling.
Downstream requirements (like transport after filling) are outside its current scope, but its specifications support seamless integration with those processes.
Draws on related standards for glass barrels, plunger stoppers, plastic barrels, and the validation of sealing/packaging processes.
Key Requirements & Specifications
The packaging must maintain sterility and protect against both particulate and bacterial contamination until the point of use.
Nests: Plastic plates with cavities that suspend individual syringe bodies, preventing contact and breakage. Must specify external dimensions, deflection tolerance, centering features, and lifting interfaces.
Tubs: Rigid containers that house the nests. Must facilitate lid sealing, have defined tolerances, and, where needed, accommodate sterilization indicators.
Insert Liners: Protective sheets over the syringes, often multi-layered for added protection and permeability to sterilant gases (like ethylene oxide).
Sealing Lids: Peelable lids that form a validated sterile barrier, compatible with the required sterilization and decontamination procedures without generating harmful particles.
Protective Bags: Layers enclosing the tub for enhanced protection. Bag properties (material, thickness, sealing) are carefully defined and tailored for automated debagging.
Marking and Labeling: Tubs must be clearly marked, and all packaging units labeled with relevant information for traceability and process control.
Collaboration between manufacturers and customers to ensure packaging suits specific machine compatibility and process requirements.
Who Should Comply?
Manufacturers of sterilized prefillable syringes
Medical device packagers and suppliers
Pharmaceutical companies involved in sterile drug preparation and automated filling lines
Practical Implications
Streamlines the integration of automated equipment for debagging, filling, and processing
Minimizes microbial risk in cleanroom environments
Facilitates higher speed filling operations and stricter process control
Reduces the risk of product loss due to packaging failure
Key highlights:
Ensures compatibility with high-speed automated pharmaceutical filling systems
Protects sterility over the entire supply chain, up to point of aseptic usage
Clarifies dimensional tolerances and performance validation for all packaging components
Access the full standard: View ISO 11040-7:2024 on iTeh Standards
ISO 11608-1:2022 - Needle-Based Injection Systems for Medical Use: Requirements and Test Methods
Needle-based injection systems for medical use — Requirements and test methods — Part 1: Needle-based injection systems
For the growing segment of needle-based injection systems—ranging from simple auto-injectors to sophisticated on-body devices—patients and health care providers depend on accuracy, reliability, and safety. ISO 11608-1:2022 provides a rigorous foundation for the design, testing, and verification of these systems, specifying essential functional, usability, and performance characteristics, while accounting for single-patient (but multi-dose) functionality and integration with prefilled or user-filled containers. This ensures that devices perform reliably and safely whether used in clinics, at home, or in innovative settings like telemedicine and pharmacy automation.
Scope & Context
Encompasses single-patient, needle-based injection systems (NISs) intended for intradermal, subcutaneous, or intramuscular delivery.
Applies to NISs with user-filled or prefilled containers, with clear exclusions for systems dedicated to continuous infusion (such as infusion pumps) and stand-alone prefilled syringes handled under other ISO standards.
Integrates risk management and usability engineering principles to minimize harm and error during use.
Focuses on bolus dosing (discrete, fixed doses) rather than continuous delivery.
Key Requirements & Specifications
Design criteria cover primary functions (dose accuracy, reliability, prevention of harm) and user interaction (ergonomics, legibility of labeling, instructions for use).
Mandates comprehensive risk management (ISO 14971) and human factors engineering (IEC 62366-1) during system design and verification.
Requires specific methods for testing:
Dose accuracy and efficiency
Life-cycle and stress testing (vibration, drop, temperature, and humidity challenges)
Marking and information legibility
Biological safety (biocompatibility, per ISO 10993-1)
Sample size rationales and test matrices must support robust design validation.
Compliance with supplementary standards for sharps injury protection (ISO 23908) and protection envelopes (IEC 60529).
Units must be free of visible defects and meet stringent marking and labeling requirements for efficient, error-free in-use operation.
Who Should Comply?
Designers and manufacturers of injectable drug delivery systems and accessories
Pharmaceutical companies integrating drugs with device platforms
Clinical engineering and regulatory affairs teams in health care institutions
Practical Implications
Accelerates regulatory approval and global market access by demonstrating robust, standardized validation
Reduces risk of device malfunction and drug dosing errors
Supports scaling of advanced therapies (e.g., biologics, specialty medications) via secure and user-friendly delivery systems
Enables seamless technology upgrades and integration in fast-evolving health care environments
Key highlights:
Addresses all primary safety and efficacy requirements for single-patient, needle-based injection devices
Stresses risk management, usability, and biocompatibility as core pillars
Builds a unified terminology and test protocol framework for all device stakeholders
Access the full standard: View ISO 11608-1:2022 on iTeh Standards
ISO 23217:2024 - Injection Systems for Self-Administration by Paediatric Patients
Injection systems for self-administration by paediatric patients — Requirements and guidelines for design
As therapies for children increasingly move beyond the clinical setting, safe and effective self-administration of medication becomes a major goal. ISO 23217:2024 addresses this emerging need, providing a blueprint for developing injection systems specifically tailored for the pediatric population. The standard incorporates child-specific human factors, regulatory requirements, and risk management strategies to ensure both the safety and usability of devices in the hands of young patients, their caregivers, and families.
Scope & Context
Sets out requirements for injectable drug delivery systems intended for self-administration by pediatric patients (children and adolescents), covering all use steps from transport and storage to operation and disposal.
Emphasizes the unique risks, user interface needs, and variability among pediatric users (age, cognitive ability, dexterity, emotional development, disease conditions).
Useful for the design of any drug delivery device intended for direct use by children, including both needle-based and alternative designs.
Catheters and infusion pumps are explicitly excluded (addressed by other standards).
Key Requirements & Specifications
Demands a formal risk assessment (aligned with ISO 14971) that accounts for pediatric-specific hazards and mitigations.
Requires usability engineering per IEC 62366-1, with special focus on human factors such as child comprehension, dexterity, attention span, and emotional state.
Recommends device features:
Visual, tactile, or auditory feedback tailored to children’s needs and abilities
Simplicity in instruction and user steps
Age-appropriate labeling and intuitive user interface elements
Safety measures to minimize the risk of error, misuse, or accidental injury
Encompasses comprehensive accompanying documentation, including user guides, quick reference materials, and multi-media education.
Stresses the importance of environmental durability (e.g., how devices withstand being carried to school, recreation, or travel scenarios).
Involves iterative user testing and validation involving actual pediatric users and their caregivers.
Who Should Comply?
Manufacturers and developers of pediatric drug delivery systems
Regulatory teams and clinical researchers involved in pediatric product trials
Pharmaceutical companies targeting the pediatric market or chronic conditions in children
Practical Implications
Reduces device-related risks and improves medication adherence in children
Ensures products are truly usable and safe in real-life contexts beyond the clinic
Strengthens market differentiation and regulatory acceptance for pediatric therapies
Supports innovation in pediatric self-management solutions, enabling digital integration and remote monitoring
Key highlights:
First international standard dedicated to pediatric self-injection systems
Integrates risk management, usability, and age-appropriate design principles
Highlights comprehensive device lifecycle, from training and preparation to maintenance and disposal
Access the full standard: View ISO 23217:2024 on iTeh Standards
Industry Impact & Compliance
The implementation of these standards provides a solid framework for health care providers, pharmaceutical manufacturers, and device developers to ensure compliance with global regulations and marketplace expectations. In an era of increased oversight and rapid innovation, such standards:
Enhance patient safety and trust: By systematically addressing infection control, usability, and product reliability
Streamline compliance: Simplifying the process for regulatory submissions and audit preparedness
Facilitate innovation: By clarifying requirements for the integration of new materials, digital features, and automation
Mitigate risk: Through thorough risk management, user-centered design, and validated performance metrics
Enable faster scaling: By reducing variability and error, making it easier to implement new processes or scale business operations
For organizations, compliance is more than a box-checking exercise—it is about building a reputation for quality, enabling global reach, and establishing resilient product lines that meet the changing demands of medicine.
The risks of non-compliance include regulatory penalties, market recall, patient harm, and significant financial and reputational damage. Conversely, proactive adoption opens new markets and solidifies customer loyalty.
Implementation Guidance
Successfully implementing these standards involves a combination of strategic planning, process control, and technical expertise:
Gap Analysis: Begin with a thorough review comparing current practices, devices, and packaging systems with standard requirements.
Training & Awareness: Educate cross-functional teams—including design, production, regulatory, and quality assurance—about the standards’ intent and application.
Supplier Collaboration: Work closely with packaging and component suppliers to ensure all materials and assemblies meet specified tolerances and validation requirements.
Process Validation: Use robust validation protocols (sterility, seal integrity, mechanical stress testing) to demonstrate compliance. Many standards reference additional guidance (e.g., ISO 11607-2 for packaging process validation).
Usability & Human Factors Engineering: For pediatric systems (ISO 23217:2024), involve end users—children, caregivers, clinicians—early and often. Conduct iterative usability testing and risk analysis throughout the development lifecycle.
Documentation & Traceability: Maintain comprehensive records, including design histories, testing outcomes, and risk management reports, to support compliance audits and market submissions.
Continuous Improvement: Monitor post-market feedback and evolve systems to anticipate requirements from upcoming technology (e.g., smart syringes, connectivity features).
Best Practices:
Use structured project management with clear milestones aligned with standard clauses
Integrate risk management from the start
Leverage automation and digital traceability where possible
Validate not only product quality but also training and educational materials (especially critical for pediatric users)
Build strong internal review and audit cycles
For further resources, industry organizations often publish implementation toolkits, webinars, and auditing frameworks to help cross the gap from intent to compliance.
Conclusion / Next Steps
The future of syringes, needles, and catheters is one of precision, automation, and patient-centered innovation. By embracing current standards like ISO 11040-7:2024, ISO 11608-1:2022, and ISO 23217:2024, health care businesses position themselves at the forefront of safety, efficiency, and scalability. These standards underpin the robust production and use of injectable devices that meet today’s demands and tomorrow’s possibilities—whether in an industrial sterile fill-finish line, an evolving home health market, or the hands of a child managing a chronic condition.
Key takeaways:
Global standardization is now a must-have for productivity and long-term growth in health care
Rigorous packaging and injection device standards reduce risk and support technology integration
Pediatric centric design is rapidly becoming both ethical and regulatory best practice
Recommendations:
Review your organization’s systems and products against these standards
Invest in training and quality improvement initiatives
Explore full standard texts and supplementary materials to guide your next innovation or compliance project
Ready to advance your syringe, needle, and catheter solutions? Explore these standards in depth and unlock the path to safer, more scalable, and more trusted health care systems.
Comments